Global Key SolutionsGKS
Guidance Documents/Guidance-Document/Labeling OTC Human Drug Products -- Questions and Answers

Labeling OTC Human Drug Products -- Questions and Answers

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

January 5, 2009

April 24, 2020

Center for Drug Evaluation and Research

fb79c331-5c94-4c61-a511-0271991af946

Related Documents

Self-Selection Studies for Nonprescription Drug Products

Guidance DocumentApril 11, 2013Center for Drug Evaluation and Research
View Details →

Labeling OTC Human Drug Products; Small Entity Compliance Guide: Guidance for Industry

Guidance DocumentMay 13, 2009Center for Drug Evaluation and Research
View Details →

Time and Extent Applications for Nonprescription Drug Products

Guidance DocumentSeptember 29, 2011Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.